CLBS03 Low Dose
CLBS03-P01
Phase 2 mab completed
Quick answer
CLBS03 Low Dose for Diabetes Mellitus is a Phase 2 program (mab) at LISATA THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LISATA THERAPEUTICS, INC.
- Indication
- Diabetes Mellitus
- Phase
- Phase 2
- Modality
- mab
- Status
- completed